Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONStandard

DUAKLIR PRESSAIR

ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE

Standard Dose
0.4MG/INH;0.012MG/INH
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DUAKLIR PRESSAIR is listed in Drugs@FDA under application 210595 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE Form and strength POWDER, METERED;INHALATION - 0.4MG/INH;0.012MG/INH Sponsor AZURITY Submission history Latest submission status date: 2019-03-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview DUAKLIR PRESSAIR is listed in Drugs@FDA under application 210595 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE Form and strength POWDER, METERED;INHALATION - 0.4MG/INH;0.012MG/INH Sponsor AZURITY Submission history Latest submission status date: 2019-03-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.